Lind Global Fund II LP 13D and 13G filings for Windtree Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 8:15 pm Sale | 2023-12-31 | 13G | Windtree Therapeutics, Inc. WINT | Lind Global Fund II LP | 16,117 5.300% | -10,278 (-38.94%) | Filing |
| 2023-04-28 4:42 pm Purchase | 2023-04-24 | 13G | Windtree Therapeutics, Inc. WINT | Lind Global Fund II LP | 26,395 9.900% | 26,395 (New Position) | Filing |